학술논문
Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models.
Document Type
Article
Author
Lücking, Ulrich; Wortmann, Lars; Wengner, Antje M.; Lefranc, Julien; Lienau, Philip; Briem, Hans; Siemeister, Gerhard; Bömer, Ulf; Denner, Karsten; Schäfer, Martina; Koppitz, Marcus; Eis, Knut; Bartels, Florian; Bader, Benjamin; Bone, Wilhelm; Moosmayer, Dieter; Holton, Simon J.; Eberspächer, Uwe; Grudzinska-Goebel, Joanna; Schatz, Christoph
Source
Journal of Medicinal Chemistry; 7/9/2020, Vol. 63 Issue 13, p7293-7325, 33p
Subject
Language
ISSN
00222623